The Journal of clinical endocrinology and metabolism
Rapid and Sustained Response of Biochemically Uncontrolled Acromegaly to Once-Daily Oral Paltusotine Treatment.
Beverly M K Biller, Alessandra Casagrande, Atanaska Elenkova, Cesar L Boguszewski, Raquel S Jallad, Beibei Hu, Erika Hubina, Pouneh K Fazeli, Maria Fleseriu, Peter J Snyder, Christian J Strasburger, Martin Bidlingmaier, Yining Zhao, Beatriz Soares, Peter J Trainer
Published: 202510.1210/clinem/dgaf579
Abstract
CONTEXT: Paltusotine is a nonpeptide, selective somatostatin receptor 2 agonist in development as once-daily oral treatment for acromegaly. OBJECTIVE: To evaluate efficacy and safety of paltusotine in patients with biochemically uncontrolled acromega…
Preview only. Read the full abstract at the source